SFM
VRNA

Sphera Funds Management’s Verona Pharma VRNA Stock Holding History

Sphera Funds Management’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-120,000
Closed -$1.23M – 87
2022
Q3 		$1.23M Buy
+120,000
New +$1.01M 0.17% 61
2022
Q2 		– Sell
-666,339
Closed -$3.33M – 82
2022
Q1 		$3.33M Sell
666,339
-134,917
-17% -$785K 0.47% 46
2021
Q4 		$5.38M Hold
801,256
– – 0.59% 55
2021
Q3 		$4.39M Hold
801,256
– – 0.37% 73
2021
Q2 		$5.24M Hold
801,256
– – 0.35% 74
2021
Q1 		$6.7M Sell
801,256
-232,347
-22% -$1.93M 0.51% 59
2020
Q4 		$7.24M Buy
1,033,603
+33,603
+3% +$227K 0.64% 51
2020
Q3 		$6.24M Buy
+1,000,000
New +$6.91M 0.61% 47

Other funds holding VRNA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Sphera Funds Management's VRNA Position: Q4 2022 in Review

Sphera Funds Management sold out of Verona Pharma (VRNA) in Q4 2022, closing a stake of 120,000 shares — an estimated $1.23M sold.

Sphera Funds Management first reported a position in VRNA in Q3 2020 and held it in 8 quarters. The position peaked at $7.24M in Q4 2020. 88 funds tracked by Wall St. Rank hold VRNA as of Q4 2022.

  • Sphera Funds Management reported no remaining Verona Pharma position as of Q4 2022 after selling out during the quarter.
  • Sphera Funds Management sold 120,000 Verona Pharma shares in Q4 2022, an estimated $1.23M.
  • Sphera Funds Management first reported a position in Verona Pharma in Q3 2020 and held it in 8 quarters.
  • Sphera Funds Management's Verona Pharma position peaked at $7.24M in Q4 2020.
  • 88 funds tracked by Wall St. Rank held Verona Pharma as of Q4 2022.

Based on Sphera Funds Management's 13F filing for Q4 2022, filed 14 Feb 2023.